| Host&Organizing Committees | President | Young-Jin Chun (Chung-Ang University) |
|---|---|---|
| Vice-President | Kyung-Chul Choi (Chungbuk National University) | |
| Secretary General | Keon-Wook Kang (Seoul National University) | |
| Scientific Committee | Chair | Ki Taek Nam (Yonsei University) Kyung-Min Lim (Ewha Womans University) |
| General Management Committee | Chair | Donghak Kim (Konkuk University) |
| Finance Committee | Chair | Jongsun Park (Chungnam National University) |
| International Relationship Committee | Chair | Byung-Sun Choi (Chung-Ang University) |
| Educational Committee | Chair | Joo Young Lee (The Catholic University of Korea) Dal Woong Choi (Korea University) |
| Program Planning Committee | Chair | Minsoo Noh (Seoul National University) |
| Public Relations and Communication Committee | Chair | Kyoung-bok Min (Seoul National University) |
| Membership Committee | Chair | Jeong-Yun Choi (Sungkyunkwan University) |
| Fundraising Committee | Chair | Kyuhong Lee (Korea Institute of Toxicology) |
| Toxicology Database Committee | Chair | Ok-Nam Bae (Hanyang University) |
| Risk Communication Advisory Committee | Chair | Kyu-Bong Kim (Dankook University) |
| Young Scientist Committee | Chair | Bumseok Kim (Chonbuk National University) |
| May 12 (Thursday), 2022 | ||
|---|---|---|
| 13:20-13:30 |
개회사 사회 : 이주영 교수 (가톨릭대학교) |
|
| 천영진 회장 (한국독성학회) | ||
| 13:30-15:30 |
Part 1 : 첨단바이오의약품의 안전성평가 및 개발동향 좌장 : 심순미 교수 (세종대학교) |
|
|
13:30-14:00 바이오의약품의 면역독성 고우석 박사 (프레스티지바이오로직스㈜) 14:00-14:30 생체 분자영상을 이용한 바이오의약품의 비임상 분포 평가 박현수 박사 (서울대학교) 14:30-15:00 항체-약물 중합체의 유효성/안전성 평가 관련 글로벌 연구 및 규제동향 이병일 박사 (㈜LG화학) 15:00-15:30 항체-약물 중합체의 특성 및 약물동태학적 특성 분석을 위한 기반기술 개발 진종화 박사 (오송첨단의료산업진흥재단) |
||
| 15:30-16:00 | Break | |
| 16:00-18:00 |
Part 2 : 살생물제의 안전성평가 및 관리 좌장 : 박용주 교수 (경성대학교) |
|
|
16:00-16:30 화학제품안전법 이행을 위한 살생물제 승인 규정의 이해 이재우 연구사 (국립환경과학원) 16:30-17:00 살생물제 구제제류의 효과·효능 시험방법 개발 및 평가 탁준형 교수 (서울대학교) 17:00-17:30 화학제품안전법상 살생물제의 독성시험 개요 엄현수 소장 (안전성평가솔루션(주)) 17:30-18:00 중대재해처벌법 이해 및 대응 김경윤 전문위원 (노무법인 더원) |
||
| 18:00-18:10 | 총평 및 폐회사 | |
| May 13 (Friday), 2022 | ||
|---|---|---|
| 09:30-9:50 |
Welcome Remarks Dr. Young-Jin Chun (President of KSOT, Chung-Ang University) Dr. Kyung Won Seo (Director General, National Institute of Food and Drug Safety Evaluation) Dr. Eun Ju Jeong (President of Korea Institute of Toxicology) |
|
| 09:50-10:30 |
Plenary Lecture I Chairperson: Dr. Hyung Sik Kim (Sungkyunkwan University) |
|
|
Key Concepts in Nonclinical Safety Assessment of Antisense Oligonucleotides (ASOs) Dr. Tae-Won Kim (IONIS Pharmaceuticals, USA) |
||
| 10:30-10:40 | Break / Exhibition Visiting | |
| 10:40-12:10 |
Session 1 The Development of mRNA Vaccine and Its Side Effects Chairperson: Dr. Ki Taek Nam (Yonsei University) |
|
|
10:40-11:10 mRNA Vaccine and Its Adverse Effect Dr. Jae-Hwan Nam (The Catholic University of Korea) 11:10-11:40 Clinical Significance of mRNA COVID-19 Vaccine Adverse Reactions Dr. Jacob Lee (Hallym University Kangnam Sacred Heart Hospital) 11:40-12:10 Myocarditis: A Serious Complication of mRNA Vaccine for COVID-19 Dr. Eun Seok Jeon (Samsung Medical Center/Sungkyunkwan University) |
||
| 12:10-13:30 | Exhibition Visiting / Council Meeting | |
| 13:30-14:10 |
Plenary Lecture II Chairperson: Dr. Tae Cheon Jeong (Yeungnam University) |
|
|
Intratracheal Therapy Using Oligodeoxynucleotides and/or Genetically Modified Lactic Acid Bacteria-derived Biological Molecules Dr. Takashi Sato (Shinshu University, Japan) |
||
| 14:10-15:40 |
Session 2 Advanced Biologics – Safety and Efficacy Issues in Preclinical and Clinical Study Chairperson: Dr. Kyung-Min Lim (Ewha Womans University) |
|
|
14:10-14:40 Forefront of In Vivo Genome Editing for Vision Dr. Jeong Hun Kim (Seoul National University Hospital) 14:40-15:10 Current Status of CAR-T, Its Pros and Cons Dr. Hyoung Jin Kang (Seoul National University Hospital) 15:10-15:40 Clinical Development of Olinvacimab and Other Novel Therapeutics Dr. Jin-San Yoo (PharmAbcine) |
||
| 15:40-16:00 | Break / Exhibition Visiting | |
| 16:00-17:30 |
Session 3 (KIT Session) Preclinical Trial Evaluation and Guidelines for Biopharmaceutical Development Chairperson: Dr. Ki-Suk Kim (Korea Institute of Toxicology) |
|
|
16:00-16:30 PBMC-humanized Mouse Models for Efficacy Evaluation of Immuno-oncology Drugs Dr. Jong Soon Kang (Korea Research Institute of Bioscience and Biotechnology) 16:30-17:00 Preclinical Safety Aspects of MSC-derived Extracellular Vesicles in Drug Development Dr. Kyoung-Sik Moon (Korea Institute of Toxicology) 17:00-17:30 Considerations on Non-clinical Assessment of Biologics Dr. Kyoung Suk Choi (Ministry of Food and Drug Safety) |
||
| 17:30-17:40 | Closing Remarks | |
Date : May. 12 (Thu) ~ 13 (Fri), 2022
In-Person & Virtual
Venue : Samsung Convention Center, Seoul National University, Seoul, Korea
Title : Current Issues in Biotherapeutics